Stocks
Haemonetics Corporation (HAE) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 48.5% | 45.5% | 45.5% | 82.1% | 21.9% | ||||
| Changes by years, y/y, % | -40pp | -3pp | 0pp | -45pp | +22.3% | ||||
Haemonetics Corporation. R&D/CAPEX, %
Haemonetics Corporation. R&D/CAPEX, changes, pp
Haemonetics Corporation (HAE) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| R&D/CAPEX, % | 59.5% | 6.25% | 144.5% | 255.7% | 175.2% | 21.9% | ||
| Changes by years, y/y, % | -16pp | -125pp | +13pp | +125pp | +124pp | |||
| Changes by quarters, q/q, % | +8pp | -53pp | +138pp | +111pp | -80pp | |||
